The most remarkable finding was the significantly increased CD3+CD56+CD8+ activation compared with non-pregnant MS women (NPMS) (p < 0.001) and even with HP (p < 0.001) (Figure 3A). Here, NCAM1 is linked to myeloid sarcoma.